ISRCTN35198481已完成不适用
Therapy of cUICC stage II/III rectal cancer of the upper third by quality controlled total versus partial mesorectal excision, followed by adjuvant chemotherapy
Georg-August University of Gottingen (Georg-August-Universitat Gottingen, Universitatsmedizin) (Germany)0 个研究点目标入组 360 人开始时间: 2008年2月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histologically confirmed advanced primary rectum carcinoma at a level 12 - 16 cm above the anocutaneous verge (as measured by rigid endoscopy), endosonographically classified as uT3-4 or uN+ carcinomas, no evidence for synchronous distant metastases
- •2. Patients aged 18 - 85 years, either sex
- •3. No preliminary treatment of rectum carcinoma
排除标准
- •1. Successfully treated secondary malignoma with the exception of basal cell carcinoma of the skin and in situ cervix carcinoma, respectively, The inclusion of patients with other tumours, that have been treated successfully and have not reappeared during the last 5 years, has to be discussed with the principal investigator
- •2. Simultaneous therapy with other anti-cancer drugs
- •3. Chronic colonic diseases
研究者
相似试验
进行中（未招募）
1 期
eoadjuvant treatment in rectal cancer with radiotherapy followed by atezolizumab and bevacizumab (TARZAN)EUCTR2018-002463-25-NLAntoni van Leeuwenhoek38
招募中
2 期
eoadjuvant treatment in rectal cancer with radiotherapy followed by atezolizumab and bevacizumab (TARZAN-trial)NL-OMON52486ederlands Kanker Instituut38
进行中（未招募）
不适用
Surgical therapy of second- or third-degree rectal prolapse using either the Altemeier or the Transtar technique: a randomised trialK62.1Rectal polypDRKS00010791Helios St.Elisabeth Klinik Oberhausen1
招募中
Unknown
Selective Neoadjuvant Therapy of Rectal Cancer Patients: SELREC - a randomized controlled, open, multicentre non-inferiority trialC20Malignant neoplasm of rectumDRKS00030567niversitätsklinikum Heidelberg; Klinik für Allgemein-, Viszeral- und Transplantationschirurgie1,074
进行中（未招募）
1 期
behandling af patienter med avanceret rectumcancer med capecitabin og oxaliplatin før under og efter kurativt intenderet strålebehandling, samt tillæg af cetuximab til patienter der er K-RAS vild-typewe will give capecitabine and oxaliplatin togehter with radiation to patient with rectum cancer T3 and T4. We will add cetuximab to patients who are K-RAS wild-typeMedDRA version: 9.1Level: LLTClassification code 10002124Term: Anal canal cancerEUCTR2009-010976-94-DKherlev hospital60